Not long ago, the idea of diagnosing a disease with a droplet of blood was considered a pipe dream. Today, this technology could soon become a reality.
Complex digital images of tissue samples that can take an experienced pathologist up to 20 minutes to annotate could be analyzed in just one minute using a new AI tool developed by researchers at the University of Cambridge.
A research team led by two University of Maine Ph.D. students developed an artificial intelligence (AI) system that could make it easier and faster for doctors to identify signs of breast cancer in tissue samples, possibly preventing delays and saving lives.
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers at UCL and UCLH.
Philips (NYSE: PHG)+ today announced the introduction of DeviceGuide, an AI-powered tracking solution for interventional cardiology.
Neocis announced today that it launched Yomi S, its next-generation robotic platform for dental implant surgery.
A new artificial intelligence tool that can create virtual representations of patients and predict individual health trajectories has been hailed a potential gamechanger for the clinical trial sector.
New platform is designed to enable fast, scalable access to a wide range of AI imaging solutions
ViTAA’s FDA clearance on its AiORTA tool represents the first part of its planned full-suite aortic care platform.
There are more candidates on the waitlist for a liver transplant than there are available organs, yet about half the time a match is found with a donor who dies after cardiac arrest following the removal of life support, the transplant must be canceled.